XM does not provide services to residents of the United States of America.
W
W

Waters

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. BlackRock, Goldman Sachs, Netflix

U.S. RESEARCH ROUNDUP-BlackRock, Goldman Sachs, Netflix July 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including BlackRock, Goldman Sachs and Netflix, on Tuesday. HIGHLIGHTS * Ameriprise Financial Inc AMP.N : RBC raises target price to $487 from $480 * BlackRock BLK.N : JP Morgan raises target price to $774 from $756 * Goldman Sachs GS.N : HSBC raises target price to $527 from $493 * Moody's Corp MCO.N : JP Morgan rai
B
G
I
N
G
S
W
A
P

U.S. STOCKS HP, Salesforce, C3.ai

BUZZ-U.S. STOCKS ON THE MOVE-HP, Salesforce, C3.ai Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes fell on Thursday, with a plummeting Salesforce weighing on the Dow, while data showing the economy had grown slower than previously expected in the first quarter supported bets of rate cuts from the Federal Reserve this year.
A
J
P
S
T
A
U
U
D
G
S
W

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change HP Inc HPQ.N +17.1% Best Buy Co Inc BBY.N +11.4% ETSY Inc ETSY.OQ +4.1% Insulet Corp PODD.OQ +4.0% Enphase Energy Inc ENPH.OQ +3.8% Bottom Performers Percent Change Salesforce Inc CRM.N -20.4% ServiceNow Inc NOW.N -9.5% Hormel Foods Co
A
S
U
E
S
W

Waters Corp dips over peer Agilent's FY revenue forecast cut

BUZZ-Waters Corp dips over peer Agilent's FY revenue forecast cut ** Shares of lab equipment maker Waters Corp WAT.N fall 5% to $310.84 in early morning trade after peer Agilent Technologies A.N lowers annual revenue forecast ** Agilent's FY forecast cut and narrow Q2 revenue est. miss on Wednesday was due to soft demand from its biotech customers
A
W

U.S. Adtran Holdings, McKesson, Waters Corp

U.S. RESEARCH ROUNDUP- Adtran Holdings, McKesson, Waters Corp May 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adtran Holdings, McKesson and Waters Corp, on Wednesday. HIGHLIGHTS * Adtran Holdings Inc ADTN.O : Jefferies cuts target price to $8.5 from $10.5 * Beyond Inc BYON.N : Jefferies cuts target price to $18 from $29 * Freshpet Inc FRPT.O : Stephens raises target price to $145 from $130 * McKesson Corp MCK.N
A
G
M
W
A
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.